New pill shows promise against advanced cancers in early trial
Disease control
Completed
This study tested an experimental drug called ART4215 in 93 people with advanced or metastatic solid tumors (cancers that have spread). The goal was to find a safe dose and see how well it works alone or combined with other cancer drugs (talazoparib or niraparib). Participants ha…
Phase: PHASE1 • Sponsor: Artios Pharma Ltd • Aim: Disease control
Last updated May 17, 2026 00:42 UTC